Product name:1H-Pyrrole-3-carboxaldehyde,5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)-

Alias: 5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde;5-(2-Fluorophenyl)-1-[(pyridin-3-yl)sulfonyl]-1H -pyrrole-3-carboxaldehyde;1H-Pyrrole-3-carboxaldehyde,5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)-;5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)- 1H-pyrrole-3-carbaldenhyde;5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)-1H-Pyrrole-3-carboxaldehyde;TAK-438(Vonoprazanfumarate)intermediate4;(5-(2-fluorophenyl)-1 -(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine; Vonoprazan-026

CAS No.:881677-11-8

Molecular formula: C16H11FN2O3S

Molecular weight: 330.33

Structural formula:

Uses:1H-Pyrrole-3-carboxaldehyde,5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)- is an intermediate in the synthesis of Vonoprazan fumarate. Vonoprazan fumarate is a novel potassium ion (K+) competitive acid blocker (P-CAB), which can inhibit the effect of K+ on H+-K+-ATPase (proton) in the last loop of gastric acid secretion in gastric parietal cells. The combination of the pump) can terminate the secretion of gastric acid in advance, and has a strong and lasting inhibitory effect on the secretion of gastric acid.